Pneumococcal vaccines for allergic airways diseases

Alison Thorburn; Phillip M Hansbro; Peter G Gibson

doi:10.1517/1472590902916999

Pneumococcal vaccines for allergic airways diseases

Alison Thorburn, Phillip M Hansbro, Peter G Gibson

Research output: Contribution to journal › Article › Research › peer-review

17 Citations (Scopus)

Abstract

BACKGROUND: Asthma is a common global health problem. Environmental exposures such as bacteria may protect against asthma development. OBJECTIVE: This review aims to examine the possible protective role of pneumococcal infection and vaccination in asthma. METHODS: A review of known experimental biology and human epidemiology relating to asthma and pneumococcal infection was performed. RESULTS: Pneumococcal infection can modulate components of allergic airways disease such as airways hyperresponsiveness and airway eosinophilia. Exposure to killed pneumococcus can reproduce these effects and the mechanism may involve control by T regulatory cells. CONCLUSIONS: Pneumococcal immunoregulatory therapy is a potentially important approach to asthma management that requires further evaluation in well-designed research studies.

Original language	English
Pages (from-to)	621 - 629
Number of pages	9
Journal	Expert Opinion on Biological Therapy
Volume	9
Issue number	5
DOIs	https://doi.org/10.1517/1472590902916999
Publication status	Published - 2009
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1517/1472590902916999

Cite this

@article{87f9885bdf5a456a994ee92196e90901,

title = "Pneumococcal vaccines for allergic airways diseases",

abstract = "BACKGROUND: Asthma is a common global health problem. Environmental exposures such as bacteria may protect against asthma development. OBJECTIVE: This review aims to examine the possible protective role of pneumococcal infection and vaccination in asthma. METHODS: A review of known experimental biology and human epidemiology relating to asthma and pneumococcal infection was performed. RESULTS: Pneumococcal infection can modulate components of allergic airways disease such as airways hyperresponsiveness and airway eosinophilia. Exposure to killed pneumococcus can reproduce these effects and the mechanism may involve control by T regulatory cells. CONCLUSIONS: Pneumococcal immunoregulatory therapy is a potentially important approach to asthma management that requires further evaluation in well-designed research studies.",

author = "Alison Thorburn and Hansbro, {Phillip M} and Gibson, {Peter G}",

year = "2009",

doi = "10.1517/1472590902916999",

language = "English",

volume = "9",

pages = "621 -- 629",

journal = "Expert Opinion on Biological Therapy",

issn = "1471-2598",

publisher = "Taylor & Francis",

number = "5",

}

TY - JOUR

T1 - Pneumococcal vaccines for allergic airways diseases

AU - Thorburn, Alison

AU - Hansbro, Phillip M

AU - Gibson, Peter G

PY - 2009

Y1 - 2009

N2 - BACKGROUND: Asthma is a common global health problem. Environmental exposures such as bacteria may protect against asthma development. OBJECTIVE: This review aims to examine the possible protective role of pneumococcal infection and vaccination in asthma. METHODS: A review of known experimental biology and human epidemiology relating to asthma and pneumococcal infection was performed. RESULTS: Pneumococcal infection can modulate components of allergic airways disease such as airways hyperresponsiveness and airway eosinophilia. Exposure to killed pneumococcus can reproduce these effects and the mechanism may involve control by T regulatory cells. CONCLUSIONS: Pneumococcal immunoregulatory therapy is a potentially important approach to asthma management that requires further evaluation in well-designed research studies.

AB - BACKGROUND: Asthma is a common global health problem. Environmental exposures such as bacteria may protect against asthma development. OBJECTIVE: This review aims to examine the possible protective role of pneumococcal infection and vaccination in asthma. METHODS: A review of known experimental biology and human epidemiology relating to asthma and pneumococcal infection was performed. RESULTS: Pneumococcal infection can modulate components of allergic airways disease such as airways hyperresponsiveness and airway eosinophilia. Exposure to killed pneumococcus can reproduce these effects and the mechanism may involve control by T regulatory cells. CONCLUSIONS: Pneumococcal immunoregulatory therapy is a potentially important approach to asthma management that requires further evaluation in well-designed research studies.

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19392578

U2 - 10.1517/1472590902916999

DO - 10.1517/1472590902916999

M3 - Article

SN - 1471-2598

VL - 9

SP - 621

EP - 629

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

IS - 5

ER -

Pneumococcal vaccines for allergic airways diseases

Abstract

UN SDGs

Access to Document

Other files and links

Cite this